Research.Patient.info
Acute Myeloid Leukemia (AML) research hub
3 indexed studies · 0 currently recruiting
- ongoing, recruitingHuman Pharmacology (Phase I)- First administration to humans
Safety of TEG001 in patients with r/r AML/high-risk MDS or r/r MM
This early-stage study is testing a new treatment called TEG001. It's for adults with certain blood cancers like acute myeloid leukaemia (AML), myelodysplastic syndrome (MDS), or multiple myeloma (MM) that have come back or are high-risk. The main goal is to see if TEG001 is safe for people to use.
Netherlands - ongoing, recruitingPhase I and Phase II (Integrated)- Other
An Open-label, Randomized Phase Ib/II Study Evaluating Safety, Tolerability, and Clinical Activity of Forimtamig-Based Treatment Combinations in Participants with Relapsed or Refractory Multiple Myeloma
Spain · Denmark · France - ongoing, recruitingHuman Pharmacology (Phase I)- First administration to humans
Dose-Escalation Study of Cevostamab in Participants with Relapsed or Refractory Multiple Myeloma
Spain